Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ChroMedX

ChroMedX
2005 FOUNDED
PUBLIC STATUS
CHX STOCK SYMBOL
1 INVESTMENTS
$0.22 SHARE PRICE (As of Friday Closing)
Description

Developer of medical devices for in vitro diagnostics and point-of-care testing. The company's medical devices consists of the HemoPalm platform, a combination of full CO-oximetry and blood gases in one handheld analyzer and the Automatic Ultra-filtration (AUF) which allow the preparation of ultra-filtrates of serum and plasma samples for measurement of free therapeutic drugs and hormones, enabling pharmaceutical companies to receive innovative devices for blood collection, analysis and plasma/serum processing.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
CNQ
Primary Office
  • 65 Queen Street West
  • Suite 520
  • Toronto, Ontario M5H 2M5
  • Canada

+1 (647) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ChroMedX’s full profile, request a free trial.

ChroMedX Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.16 - $0.60 $17.8M $0.22 -$0.05 68.6K 81.9M

ChroMedX Financials Summary

In Thousands,
USD
TTM
31-Dec-2017
FY 2017
30-Sep-2017
FY 2016
30-Sep-2016
FY 2015
30-Sep-2015
Enterprise Value 32,664 15,779 5,111 10,176
EBITDA (3,102) (2,455) (831) (1,438)
Net Income (3,605) (2,952) (1,324) (1,712)
Total Assets 2,565 1,840 1,948 2,597
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ChroMedX Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ChroMedX‘s full profile, request access.

Request full access to PitchBook

ChroMedX Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 0000 00000000 09-May-2018 000000000000000000 00.000 Monitoring Equipment 00000 000
To view this company’s complete investment and acquisition history, request access »

ChroMedX Executive Team (5)

Name Title Board
Seat
Contact
Info
Ash Kaushal President, Chief Executive Officer and Director
Lahav Gil Chief Executive Officer
Chris Hopkins Chief Financial Officer
James Samsoondar Ph.D Co-Founder, Director & Chief Scientific Officer
Lorna Samsoondar Co-Founder & Advisor